A Photoacoustic Contrast Nanoagent with a Distinct Spectral Signature for Ovarian Cancer Management
Sign Up to like & getrecommendations! Published in 2022 at "Advanced Healthcare Materials"
DOI: 10.1002/adhm.202202946
Abstract: Photoacoustic imaging (PAI) has tremendous potential for improving ovarian cancer detection. However, the lack of effective exogenous contrast agents that can improve PAI diagnosis accuracy significantly limits this application. This study presents a novel contrast… read more here.
Keywords: spectral signature; contrast; ovarian cancer; contrast nanoagent ... See more keywords